摘要
背景:蛋白毒性应激和转化生长因子(TGFβ)诱导的上皮间质转化(EMT)是眼内纤维化病变的两个主要原因,包括增生性玻璃体视网膜病变(PVR)和增殖性糖尿病视网膜病变(PDR)。但是,这两个因素如何相互交流还没有得到很好的表征。 目的:研究蛋白毒性应激对视网膜色素上皮细胞TGFβ信号通路的调节作用。 方法:用蛋白酶体抑制剂MG132和TGFβ处理ARPE-19细胞和原代人视网膜色素上皮(RPE)细胞。通过CCK-8测定分析细胞增殖。通过实时聚合酶链反应(PCR),蛋白质印迹和免疫荧光分析间充质标志物α-SMA,纤连蛋白和波形蛋白的水平。通过划伤伤口分析来分析细胞迁移。 Western blot检测p-Smad2,Smad2,p-ERK1 / 2,ERK1 / 2,p-FAK和FAK的表达。实时荧光定量PCR和Western blot分别检测TGFβ受体-Ⅱ(TGFβR-Ⅱ)的mRNA和蛋白水平。 结果:MG132诱导的蛋白毒性应激导致细胞增殖减少。 MG132显着抑制TGFβ诱导的α-SMA,纤连蛋白和波形蛋白的上调以及TGFβ诱导的细胞迁移。 Smad2,ERK1 / 2和FAK的磷酸化水平也被MG132抑制。此外,MG132处理后,TGFβR-II的mRNA水平和蛋白水平降低。 结论:蛋白毒性应激通过下调TGFβR-II抑制TGFβ诱导的EMT,从而阻断Smad2,ERK1 / 2和FAK的激活。
关键词: 蛋白毒性应激,视网膜色素上皮细胞,转化生长因子,上皮 - 间质转化,增殖性玻璃体视网膜病变,糖尿病视网膜病变。
Current Molecular Medicine
Title:Proteotoxic Stress Desensitizes TGF-beta Signaling Through Receptor Downregulation in Retinal Pigment Epithelial Cells
Volume: 17 Issue: 3
关键词: 蛋白毒性应激,视网膜色素上皮细胞,转化生长因子,上皮 - 间质转化,增殖性玻璃体视网膜病变,糖尿病视网膜病变。
摘要: Background: Proteotoxic stress and transforming growth factor (TGFβ)- induced epithelial-mesenchymal transition (EMT) are two main contributors of intraocular fibrotic disorders, including proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR). However, how these two factors communicate with each other is not well-characterized.
Objective: The aim was to investigate the regulatory role of proteotoxic stress on TGFβ signaling in retinal pigment epithelium.
Methods: ARPE-19 cells and primary human retinal pigment epithelial (RPE) cells were treated with proteasome inhibitor MG132 and TGFβ. Cell proliferation was analyzed by CCK-8 assay. The levels of mesenchymal markers α-SMA, fibronectin, and vimentin were analyzed by real-time polymerase chain reaction (PCR), western blot, and immunofluorescence. Cell migration was analyzed by scratch wound assay. The levels of p-Smad2, total Smad2, p-extracellular signal-regulated kinase 1/2 (ERK1/2), total ERK1/2, p-focal adhesion kinase (FAK), and total FAK were analyzed by western blot. The mRNA and protein levels of TGFβ receptor-II (TGFβR-II) were measured by realtime PCR and western blot, respectively.
Results: MG132-induced proteotoxic stress resulted in reduced cell proliferation. MG132 significantly suppressed TGFβ-induced upregulation of α-SMA, fibronectin, and vimentin, as well as TGFβ-induced cell migration. The phosphorylation levels of Smad2, ERK1/2, and FAK were also suppressed by MG132. Additionally, the mRNA level and protein level of TGFβR-II decreased upon MG132 treatment.
Conclusion: Proteotoxic stress suppressed TGFβ-induced EMT through downregulation of TGFβR-II and subsequent blockade of Smad2, ERK1/2, and FAK activation.
Export Options
About this article
Cite this article as:
Proteotoxic Stress Desensitizes TGF-beta Signaling Through Receptor Downregulation in Retinal Pigment Epithelial Cells, Current Molecular Medicine 2017; 17 (3) . https://dx.doi.org/10.2174/1566524017666170619113435
DOI https://dx.doi.org/10.2174/1566524017666170619113435 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drosophila Lethal Giant Larvae Neoplastic Mutant as a Genetic Tool for Cancer Modeling
Current Genomics Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Strategies for Targeting Lentiviral Vectors
Current Gene Therapy Nucleic Acids as Therapeutic Agents
Current Topics in Medicinal Chemistry Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders
Central Nervous System Agents in Medicinal Chemistry Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Current Cancer Drug Targets Aptamers Overview: Selection, Features and Applications
Current Topics in Medicinal Chemistry Artificial Intelligence for Epigenetics: Towards Personalized Medicine
Current Medicinal Chemistry From Chemical Graphs in Computer-Aided Drug Design to General Markov-Galvez Indices of Drug-Target, Proteome, Drug-Parasitic Disease, Technological, and Social-Legal Networks
Current Computer-Aided Drug Design Prospects and Limitations of T Cell Receptor Gene Therapy
Current Gene Therapy Brachytherapy: State of the Art and Possible Improvements
Anti-Cancer Agents in Medicinal Chemistry MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets Emerging Role for αB-Crystallin as a Therapeutic Agent: Pros and Cons
Current Molecular Medicine Innovative Strategies in In Vivo Apoptosis Imaging
Current Medicinal Chemistry Inflammatory Process in Parkinsons Disease: Role for Cytokines
Current Pharmaceutical Design Evaluation of a Polymer-Lipid-Polymer System Utilising Hybrid Nanoparticles of Dapsone as a Novel Antiacne Agent
Current Drug Therapy A Proteome-Level Computational Biology Insight on Sequence Based Aggregation Propensity Profile of Human Hydrolase Structural Enzymes
Current Biotechnology C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
Current Neuropharmacology Human Ghrelin: A Gastric Hormone with Cardiovascular Properties
Current Pharmaceutical Design Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery